Clin2
NCT07604974Likely a fitRecruiting

Safety and effectiveness of ION775 for very high triglycerides

HypertriglyceridemiaSevere Hypertriglyceridemia

Part of Hormones & metabolism clinical trials.

This trial tests a new medicine called ION775 to help lower very high triglyceride levels in the blood. Triglycerides are a type of fat, and having too much can increase heart disease risk. The study will check if ION775 is safe and actually works when added to your regular cholesterol medications.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
72 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • Age 18 or older
  • Fasting triglyceride level of 350 mg/dL or higher (or 500 mg/dL or higher for severe cases)
  • Currently taking standard cholesterol or triglyceride-lowering medications
  • Liver function and kidney function within acceptable ranges
  • Blood sugar control reasonably managed (HbA1c below 8.5%)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07028749Recruiting· Phase 2
Study of an experimental drug for high triglycerides and remnant cholesterol

This trial tests an investigational medication, MAR001, to see if it can lower high levels of fats in the blood (triglycerides and remnant cholesterol) linked to heart disease. If you have these conditions, this treatment might help reduce your risk.

Anniston, Alabama
NCT07140809Recruiting· Phase 1/Phase 2
Study of JMT202 for people with high triglycerides

This trial tests a new injectable drug, JMT202, for people with high triglycerides (a type of fat in the blood). The goal is to see if it safely lowers triglycerides and may reduce heart risk.

Beijing, Beijing Municipality
NCT07693777Not yet recruiting· Phase 3
Testing DR10624 for severe high triglycerides

This trial tests a new injectable drug called DR10624 for people with very high triglyceride levels. It aims to lower triglycerides and reduce the risk of pancreatitis (inflammation of the pancreas).

Shanghai
NCT07349615Recruiting· Phase 3
Study of SHR-1918 for high triglycerides

This trial tests a new medication, SHR-1918, to lower high triglyceride levels. It may be an option for people with moderately elevated triglycerides and controlled cholesterol.

Shanghai, Shanghai Municipality
NCT06564584Recruiting· Phase 2
Study of TLC-2716 for high triglycerides and fatty liver disease

This trial tests an investigational drug called TLC-2716 for people with very high triglycerides and a type of fatty liver disease (NAFLD or NASH). The goal is to see if it is safe and can help lower fat levels in the blood and liver.

Guadalajara, Jalisco
NCT07199309Recruiting· Phase 2
Study of MAR001 for people with high triglycerides and remnant cholesterol

This study tests a new medicine called MAR001 in people with high triglycerides and remnant cholesterol, which are types of fats in the blood. It aims to see if the medicine can improve these levels while you stick to your usual diet and medications.

Chula Vista, California

Hear when a new Hypertriglyceridemia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.